ASH 2016: Which Patients With Chronic Lymphocytic Leukemia (CLL) Become Resistant to Ibrutinib
Labels: ASH 2016, Chronic lymphocytic leukemia, CLL, Dr. Wiestner, ibrutinib, resistance
What started as a personal journey of a doctor turned patient morphed into a way to share what’s universal in dealing with cancer, in my case a nasty leukemia (CLL), a failed transplant and a successful clinical trial. The telling of my journey has become a journey to teach about CLL, related blood issues and all cancers. Please visit our new website http://cllsociety.org for the latest news and information. Smart patients get smart care™. If you want to reach me, email bkoffmanMD@gmail.com
Labels: ASH 2016, Chronic lymphocytic leukemia, CLL, Dr. Wiestner, ibrutinib, resistance
1 Comments:
Hi Brian,
My name is Anuj Agarwal. I'm Founder of Feedspot.
I would like to personally congratulate you as your blog Learning From And About Cancer has been selected by our panelist as one of the Top 50 Leukemia Blogs on the web.
http://blog.feedspot.com/leukemia_blogs/
I personally give you a high-five and want to thank you for your contribution to this world. This is the most comprehensive list of Top 50 Leukemia Blogs on the internet and I’m honored to have you as part of this!
Also, you have the honor of displaying the badge on your blog.
best,
Anuj
Post a Comment
Subscribe to Post Comments [Atom]
<< Home